Status:

ENROLLING_BY_INVITATION

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Lead Sponsor:

AstraZeneca

Conditions:

Ovarian Cancer

Breast Cancer

Eligibility:

All Genders

18-99 years

Phase:

PHASE3

Brief Summary

The rationale of the ROSY-O study is to continue to provide study treatment for patients who have participated in a parent study with olaparib and who are continuing to derive clinical benefit from tr...

Detailed Description

ROSY-O is an open label, non-randomised, multicentre,international trial for patients who have completed a parent study using olaparib and who are deriving clinical benefit from continued treatment as...

Eligibility Criteria

Inclusion

  • Provision of signed and dated, written ICF.
  • Patient is currently deriving clinical benefit, as judged by the Investigator, from continued treatment in an AZ parent study using an AstraZeneca (AZ) compound that has met its endpoints or has otherwise stopped.
  • Patient participating in a prior oncology study with an AZ compound in which they received olaparib and are continuing to receive clinical benefit from treatment; the prior study can be an open-label or blinded study, with unblinding at study close.

Exclusion

  • Ongoing, unresolved, Grade 3 or above toxicity requiring interruption of treatment at the time of the termination of the parent study.
  • Currently receiving treatment with any prohibited medication(s).
  • Concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.
  • Permanent discontinuation from the parent study due to toxicity or disease progression.
  • Local access to commercially-available drug at no cost to the patient is permitted by local regulation.

Key Trial Info

Start Date :

August 4 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 6 2027

Estimated Enrollment :

267 Patients enrolled

Trial Details

Trial ID

NCT04421963

Start Date

August 4 2020

End Date

April 6 2027

Last Update

July 29 2025

Active Locations (110)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 28 (110 locations)

1

Research Site

West Hollywood, California, United States, 90048

2

Research Site

Boca Raton, Florida, United States, 33486

3

Research Site

Towson, Maryland, United States, 21204

4

Research Site

Detroit, Michigan, United States, 48201